Negative symptoms in schizophrenia: psychotherapeutic approaches

被引:0
作者
Azorin, J. -M. [1 ]
Adida, M. [1 ]
Belzeaux, R. [1 ]
Pringuey, D. [2 ]
Franchi, J. -A. Micoulaud [3 ,4 ]
Simon, N. [5 ]
Cermolacce, M. [1 ]
Kaladjian, A. [6 ]
Fakra, E. [7 ]
机构
[1] Hop St Marguerite, SHU Psychiat Adultes, F-13274 Marseille 9, France
[2] UNSA, Fac Med Nice, F-06107 Nice, France
[3] CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, F-33076 Bordeaux, France
[4] Univ Bordeaux, CHU Pellegrin, CNRS, USR 3413,SANPSY, Bordeaux, France
[5] Hop St Marguerite, CAP TV, Serv Pharmacol Clin, F-13274 Marseille 9, France
[6] CHU Robert Debre, Serv Psychiat Adultes, F-51092 Reims, France
[7] CHU St Etienne, Serv Psychiat Adultes, F-42055 St Etienne 2, France
来源
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 2015年 / 41卷
关键词
Negative symptoms; Anhedonia; Avolition; Apathy; Psychotherapy; RANDOMIZED-TRIAL; THERAPY;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although negative symptoms are recognized as a central feature of schizophrenia, their definition as well as phenomenology have long been a vexing issue. During these last years, a major progress has been made with the delineation of two underlying subdomains of negative symptoms: diminished expression and anhedonia-avolition-apathy. As current guidelines are not always in accord on the efficacy of treatments on negative symptoms, it may be tempting to re-interpret the findings of clinical trials by looking at the effects of treatments on these two subdomains. This could concern both psychotropic treatments and psychotherapeutic interventions. Furthermore, neuroimaging as well as emotional response studies have permitted to better understand the mechanism which could be at the root of diminished expression and anhedonia in schizophrenia. On this basis, new psychotherapeutic methods have been devised which, by specifically targeting these two subdomains, are likely to be more efficient on negative symptoms. Further research is warranted to test their efficacy in randomized controlled trials. (C) L'Encephale, Paris, 2015. All rights reserved.
引用
收藏
页码:6S57 / 6S60
页数:4
相关论文
共 20 条
[1]  
[Anonymous], IRAN J NURS MIDWIFER
[2]  
[Anonymous], 2011, KOBE J MED SCI
[3]  
Association AP, 2013, Text Revision DSM-5-TR, DOI DOI 10.1176/APPI.BOOKS.9780890425596.744053
[4]   Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading [J].
Azorin, Jean-Michel ;
Belzeaux, Raoul ;
Adida, Marc .
CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (09) :801-808
[5]   The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements [J].
Buchanan, Robert W. ;
Kreyenbuhl, Julie ;
Kelly, Deanna L. ;
Noel, Jason M. ;
Boggs, Douglas L. ;
Fischer, Bernard A. ;
Himelhoch, Seth ;
Fang, Beverly ;
Peterson, Eunice ;
Aquino, Patrick R. ;
Keller, William .
SCHIZOPHRENIA BULLETIN, 2010, 36 (01) :71-93
[6]   The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia [J].
Conley, Robert R. ;
Boggs, Douglas L. ;
Kelly, Deanna L. ;
McMahon, Robert P. ;
Dickinson, Dwight ;
Feldman, Stephanie ;
Ball, M. Patricia ;
Buchanan, Robert W. .
CLINICAL NEUROPHARMACOLOGY, 2009, 32 (02) :69-74
[7]   Anticipatory Pleasure Skills Training: A New Intervention to Reduce Anhedonia in Schizophrenia [J].
Favrod, Jerome ;
Giuliani, Fabienne ;
Ernst, Fanny ;
Bonsack, Charles .
PERSPECTIVES IN PSYCHIATRIC CARE, 2010, 46 (03) :171-181
[8]   Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia [J].
Grant, Paul M. ;
Huh, Gloria A. ;
Perivoliotis, Dimitri ;
Stolar, Neal M. ;
Beck, Aaron T. .
ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (02) :121-127
[9]   Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia [J].
Gur, Raquel E. ;
Loughead, James ;
Kohler, Christian G. ;
Elliott, Mark A. ;
Lesko, Kathleen ;
Ruparel, Kosha ;
Wolf, Daniel H. ;
Bilker, Warren B. ;
Gur, Ruben C. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (12) :1356-+
[10]   World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance [J].
Hasan, Alkomiet ;
Falkai, Peter ;
Wobrock, Thomas ;
Lieberman, Jeffrey ;
Glenthoj, Birte ;
Gattaz, Wagner F. ;
Thibaut, Florence ;
Moeller, Hans-Juergen .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2012, 13 (05) :318-378